公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV | Chen, Guan-Jhou; Lee, Yu-Lin; Lee, Chen-Hsiang; HSIN-YUN SUN ; Cheng, Chien-Yu; Tsai, Hung-Chin; Huang, Sung-Hsi; Lee, Yi-Chieh; Hsieh, Min-Han; SUI-YUAN CHANG ; YU-CHUNG CHUANG ; Su, Li-Shin; Chang, Sui-Fang; Tang, Hung-Jen; CHIEN-CHING HUNG | Journal of Antimicrobial Chemotherapy | 6 | 6 | |
2012 | Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010 | Huang, Chi-Chang; Chen, Yao-Shen; Toh, Han-Siong; Lee, Yu-Lin; Liu, Yuag-Meng; Ho, Cheng-Mao; Lu, Po-Liang; Liu, Chun-Eng; Chen, Yen-Hsu; Wang, Jen-Hsien; Tang, Hung-Jen; Yu, Kwok-Woon; Liu, Yung-Ching; Chuang, Yin-Ching; Xu, Yingchun; Ni, Yuxing; Ko, Wen-Chien; Hsueh, Po-Ren | Int. J. Antimicrob. Agents | | | |
2023 | In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021 | Lee, Yu-Lin; Ko, Wen-Chien; PO-REN HSUEH | International journal of antimicrobial agents | 2 | 0 | |
2021 | In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020 | Liu, Po-Yu; Ko, Wen-Chien; Lee, Wen-Sen; Lu, Po-Liang; Chen, Yen-Hsu; Cheng, Shu-Hsing; Lu, Min-Chi; Lin, Chi-Ying; Wu, Ting-Shu; Yen, Muh-Yong; Wang, Lih-Shinn; Liu, Chang-Pan; PEI-LAN SHAO ; Lee, Yu-Lin; Shi, Zhi-Yuan; Chen, Yao-Shen; Wang, Fu-Der; Tseng, Shu-Hui; Lin, Chao-Nan; Chen, Yu-Hui; WANG-HUEI SHENG ; Lee, Chun-Ming; Tang, Hung-Jen; PO-REN HSUEH | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 17 | 10 | |
2023 | In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020 | Chang, Chih-Yen; Lee, Yu-Lin; YU-TSUNG HUANG ; Ko, Wen-Chien; Ho, Mao-Wang; PO-REN HSUEH | International journal of antimicrobial agents | 0 | 0 | |
2023 | In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020 | Liu, Yuag-Meng; Ko, Wen-Chien; Ho, Mao-Wang; Lee, Yu-Lin; PO-REN HSUEH | The Journal of infection | 2 | 2 | |
2022 | In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam: Data from the Antimicrobial Testing Leadership and Surveillance Programme, 2012-2019 | Jean, Shio-Shin; Lee, Yu-Lin; Hsu, Chin-Wang; PO-REN HSUEH | International journal of antimicrobial agents | 2 | 0 | |
2023 | In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020 | Lee, Yu-Lin; Liu, Chun-Eng; Ko, Wen-Chien; PO-REN HSUEH | International journal of antimicrobial agents | 2 | 0 | |
2021 | In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020 | Lee, Yu-Lin; Ko, Wen-Chien; Lee, Wen-Sen; Lu, Po-Liang; Chen, Yen-Hsu; Cheng, Shu-Hsing; Lu, Min-Chi; Lin, Chi-Ying; Wu, Ting-Shu; Yen, Muh-Yong; Wang, Lih-Shinn; Liu, Chang-Pan; PEI-LAN SHAO ; Chen, Yao-Shen; Chen, Yao-Shen; Tseng, Shu-Hui; Tseng, Shu-Hui; Lin, Chao-Nan; Sheng, Wang-Huei; WANG-HUEI SHENG ; Lee, Chun-Ming; Tang, Hung-Jen; PO-REN HSUEH | International journal of antimicrobial agents | 16 | 12 | |
2021 | Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan | Lin, Yi-Chun; Lee, Yu-Lin; Cheng, Chien-Yu; WEN-PIN TSENG ; JHONG-LIN WU ; CHIEN-HAO LIN ; Chung, Ming-Yi; CHUN-MIN KANG ; Huang, Chien-Hua; Chen, Cheng-Pin; CHIEN-HUA HUANG ; Liu, Chun-Eng; Cheng, Shu-Hsing; SHYR-CHYR CHEN ; SHEY-YING CHEN ; PO-REN HSUEH | Journal of microbiology, immunology, and infection | 8 | 6 | |
2020 | Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan | SHEY-YING CHEN ; Lee, Yu-Lin; Lin, Yi-Chun; Lee, Nan-Yao; Liao, Chia-Hung; Hung, Yuan-Pin; Lu, Min-Chi; JHONG-LIN WU ; WEN-PIN TSENG ; CHIEN-HAO LIN ; Chung, Ming-Yi; CHUN-MIN KANG ; Lee, Ya-Fan; Lee, Tai-Fen; Cheng, Chien-Yu; Chen, Cheng-Pin; CHIEN-HUA HUANG ; Liu, Chun-Eng; Cheng, Shu-Hsing; Ko, Wen-Chien; PO-REN HSUEH ; SHYR-CHYR CHEN | Emerging microbes & infections | 33 | 31 | |
2021 | Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018 | Jean, Shio-Shin; Lee, Yu-Lin; Liu, Po-Yu; Lu, Min-Chi; Ko, Wen-Chien; PO-REN HSUEH | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 29 | 20 | |
2021 | National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020 | YING-CHUN CHIEN ; Lee, Yu-Lin; Liu, Po-Yu; Lu, Min-Chi; PEI-LAN SHAO ; Lu, Po-Liang; Cheng, Shu-Hsing; Lin, Chi-Ying; Wu, Ting-Shu; Yen, Muh-Yong; Wang, Lih-Shinn; Liu, Chang-Pan; Lee, Wen-Sen; Shi, Zhi-Yuan; Chen, Yao-Shen; Wang, Fu-Der; Tseng, Shu-Hui; Chen, Yu-Hui; WANG-HUEI SHENG ; Lee, Chun-Ming; Chen, Yen-Hsu; Ko, Wen-Chien; PO-REN HSUEH | Journal of Global Antimicrobial Resistance | 5 | 3 | |
2022 | Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019 | Tsai, Yu-Te; Lee, Yu-Lin; Lu, Min-Chi; PEI-LAN SHAO ; Cheng, Shu-Hsing; Cheng, Shu-Hsing; Ko, Wen-Chien; Lin, Chi-Ying; Yen, Muh-Yong; Wang, Lih-Shinn; Wang, Lih-Shinn; Liu, Chang-Pan; Shi, Zhi-Yuan; Chen, Yao-Shen; Chen, Yao-Shen; Tseng, Shu-Hui; Tseng, Shu-Hui; Lin, Chao-Nan; Sheng, Wang-Huei; WANG-HUEI SHENG ; Lee, Chun-Ming; Tang, Hung-Jen; Chen, Yen-Hsu; Chen, Yen-Hsu; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 3 | 2 | |
2023 | Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021 | Lee, Yu-Lin; PO-REN HSUEH | The Journal of infection | 2 | 1 | |
2023 | A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV | Cheng, Shu-Hsing; Lien, Chia En; SZU-MIN HSIEH ; Cheng, Chien-Yu; WANG-DA LIU ; Lo, Ching-Lung; Ko, Wen-Chien; Chen, Yen-Hsu; Huang, Ching-Tai; Chang, Hsiao-Ting; Hwang, Shinn-Jang; Wang, Ning-Chi; Liu, Ming-Che; Lee, Yu-Lin; Tai, I-Chen; Estrada, Josue Antonio Garcia; Lin, Tzou-Yien; Lee, Wen-Sen | Vaccines | 4 | 2 | |
2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | SZU-MIN HSIEH ; Liu, Ming-Che; Chen, Yen-Hsu; Lee, Wen-Sen; Hwang, Shinn-Jang; Cheng, Shu-Hsing; Ko, Wen-Chien; Hwang, Kao-Pin; Wang, Ning-Chi; Lee, Yu-Lin; Lin, Yi-Ling; Shih, Shin-Ru; Huang, Chung-Guei; Liao, Chun-Che; Liang, Jian-Jong; Chang, Chih-Shin; Chen, Charles; Lien, Chia En; Tai, I-Chen; Lin, Tzou-Yien | The Lancet. Respiratory medicine | 87 | 81 | |
2007 | 分割策略應用於解決多角化問題之研究-以個案公司為例 | 李宇玲; Lee, Yu-Lin | | | | |
2005 | 工業電腦廠商發展代工業務之個案研究—以研華公司為例 | 李侑霖; Lee, Yu-Lin | | | | |